Cargando…
Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods
Shiga toxin (Stx)-producing Escherichia coli (STEC) infection is associated with a broad spectrum of clinical manifestations that include diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). Systemic Stx toxemia is considered to be central to the genesis of HUS. Distinct methods have...
Autores principales: | Fernández-Brando, Romina J., Bentancor, Leticia V., Mejías, María Pilar, Ramos, María Victoria, Exeni, Andrea, Exeni, Claudia, Laso, María del Carmen, Exeni, Ramón, Isturiz, Martín A., Palermo, Marina S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084754/ https://www.ncbi.nlm.nih.gov/pubmed/21559455 http://dx.doi.org/10.1371/journal.pone.0019136 |
Ejemplares similares
-
Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Abrey Recalde, Maria J., et al.
Publicado: (2017) -
Role of Polymorphonuclear Leukocytes in the Pathophysiology of Typical Hemolytic Uremic Syndrome
por: Exeni, Ramón A., et al.
Publicado: (2007) -
Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells
por: Bentancor, Leticia V., et al.
Publicado: (2013) -
Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
por: Mejías, Maria P., et al.
Publicado: (2016) -
Assessment of interleukin-10 promoter variant (−1082A/G) and cytokine production in patients with hemolytic uremic syndrome
por: Mongelos, Micaela Aldana, et al.
Publicado: (2023)